Literature DB >> 21525526

Circadian variations of infarct size in acute myocardial infarction.

Aida Suárez-Barrientos1, Pedro López-Romero, David Vivas, Francisco Castro-Ferreira, Ivan Núñez-Gil, Eduardo Franco, Borja Ruiz-Mateos, Juan Carlos García-Rubira, Antonio Fernández-Ortiz, Carlos Macaya, Borja Ibanez.   

Abstract

BACKGROUND: The circadian clock influences a number of cardiovascular (patho)physiological processes including the incidence of acute myocardial infarction. A circadian variation in infarct size has recently been shown in rodents, but there is no clinical evidence of this finding.
OBJECTIVE: To determine the impact of time-of-day onset of ST segment elevation myocardial infarction (STEMI) on infarct size.
METHODS: A retrospective single-centre analysis of 811 patients with STEMI admitted between 2003 and 2009 was performed. Infarct size was estimated by peak enzyme release. The relationship between peak enzyme concentrations and time-of-day were characterised using multivariate regression splines. Time of STEMI onset was divided into four 6-hour periods in phase with circadian rhythms.
RESULTS: Model comparisons based on likelihood ratio tests showed a circadian variation in infarct size across time-of-day as evaluated by peak creatine kinase (CK) and troponin-I (TnI) concentrations (p=0.015 and p=0.012, respectively). CK and TnI curves described similar patterns across time, with a global maximum in the 6:00-noon period and a local minimum in the noon-18:00 period. Infarct size was largest in patients with STEMI onset in the dark-to-light transition period (6:00-noon), with an increase in peak CK and TnI concentrations of 18.3% (p=0.031) and 24.6% (p=0.033), respectively, compared with onset of STEMI in the 18:00-midnight period. Patients with anterior wall STEMI also had significantly larger infarcts than those with STEMI in other locations.
CONCLUSIONS: Significant circadian oscillations in infarct size were found in patients according to time-of-day of STEMI onset. The infarct size was found to be significantly larger with STEMI onset in the dark-to-light transition period (6:00-noon). If confirmed, these results may have a significant impact on the interpretation of clinical trials of cardioprotective strategies in STEMI.

Entities:  

Mesh:

Year:  2011        PMID: 21525526     DOI: 10.1136/hrt.2010.212621

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  50 in total

1.  Circadian and weekly variation and the influence of environmental variables in acute myocardial infarction.

Authors:  I Wijnbergen; M Van't Veer; N H J Pijls; J Tijssen
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

Review 2.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Chronic phase advance alters circadian physiological rhythms and peripheral molecular clocks.

Authors:  Gretchen Wolff; Marilyn J Duncan; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2013-05-23

Review 4.  Health implications of disrupted circadian rhythms and the potential for daylight as therapy.

Authors:  Jason Brainard; Merit Gobel; Benjamin Scott; Michael Koeppen; Tobias Eckle
Journal:  Anesthesiology       Date:  2015-05       Impact factor: 7.892

Review 5.  Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein.

Authors:  Stephanie Bonney; Kelly Hughes; Patrick N Harter; Michel Mittelbronn; Lori Walker; Tobias Eckle
Journal:  Int J Biochem Cell Biol       Date:  2013-01-03       Impact factor: 5.085

Review 6.  Anesthetic cardioprotection: the role of adenosine.

Authors:  Stephanie Bonney; Kelly Hughes; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Circadian rhythms in leukocyte trafficking.

Authors:  David Druzd; Alba de Juan; Christoph Scheiermann
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

8.  ADORA2b Signaling in Cardioprotection.

Authors:  Jennifer Gile; Tobias Eckle
Journal:  J Nat Sci       Date:  2016

Review 9.  Targets, trafficking, and timing of cardiac autophagy.

Authors:  David Rotter; Beverly A Rothermel
Journal:  Pharmacol Res       Date:  2012-10-08       Impact factor: 7.658

10.  The effect of acetylsalicylic acid dosed at bedtime on the anti-aggregation effect in patients with coronary heart disease and arterial hypertension: A randomized, controlled trial.

Authors:  Beata Krasińska; Lech Paluszkiewicz; Ewa Miciak-Lawicka; Maciej Krasiński; Piotr Rzymski; Andrzej Tykarski; Zbigniew Krasiński
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.